Poultry coccidiosis control with live Eimeria vaccines (and phytogenic support) instead of continuous in-feed ionophores and chemical coccidiostats
Ionophore coccidiostats (monensin, salinomycin, narasin, lasalocid, maduramicin, semduramicin) and chemical anticoccidials (nicarbazin, diclazuril, robenidine, halofuginone, decoquinate) fed continuously
Suppliers 5
| Vaksindo Animal Health | Indonesia | active |
| Biocamp Laboratórios Ltda | Brazil | active |
| Liselo Labs | South Africa | active |
| MSD Animal Health Poultry and Swine Sub Sahara Africa | South Africa | active |
| International Free Trade Corporation - IFT | Egypt | active |
Route into Russia / EAEU VET
- Regulator
- Rosselkhoznadzor
- Typical time
- 155-235 working days under EAEU rules (plus dossier); national 61-FZ route open until 31.12.2027
- Legal basis
- EEC Council Decision No. 1 (21.01.2022), EAEU rules for veterinary medicines; Federal Law 61-FZ (national procedure until 2027)
Information, not legal advice — confirm the procedure for your product.
Proof 7 claims
In-feed anticoccidial ionophores and chemical coccidiostats.
Live oocyst coccidiosis vaccination (at day of hatch).
- Displaced at scale?
- partly
- Caveats
- The evidence does not show a global displacement of ionophores by live vaccines. In Canada, coccidiosis vaccine use in broilers declined from 18% in 2018 to 8% in 2023, and in the U.S., ionophores remain a primary control method, though their use has seen reductions alongside other antimicrobial usage changes. Complete displacement is only documented in specific national contexts like Norway.
- Hand review
- D2 One national survey: live coccidiosis vaccines used in 13% of broiler, 16% of turkey and 29% of layer flocks (peer-reviewed).
- checked
- 2026-10-06
| Norway discontinued the prophylactic use of coccidiostats in 2016 and transitioned all broiler flocks to routine vaccination with live attenuated Eimeria oocysts. “Norway discontinued the prophylactic use of coccidiostats in broiler production in 2016, and all broilers are now raised without the routine use of coccidiostats. As an alternative strategy to control coccidiosis, all broiler flocks in Norway are now routinely vaccinated at hatch with vaccines based on live attenuated …” Norway · 2016-present · large measured reduction of the old process | weak (company, news, market research, other) rvc-repository.worktribe.com |
| Large-scale field trials showed that vaccination increased the production index (PI) by 2.45 to 23.55 compared to previous trials. “Compared with the PI of the previous 9–10 trials on each farm, the PI increased by 2.45 to 23.55.” unspecified (likely South Korea based on context) · 2021-2023 · pilot or niche | peer-reviewed pmc.ncbi.nlm.nih.gov |
| In Belgian field trials, the use of a live coccidiosis vaccine reduced the days of enteric antibiotic treatment per cycle by 16.14% during vaccination and 45.24% after vaccination. “There is a reduction with regard to the days of treatment per cycle of 16.14% during (CDV) and 45.24% after vaccination (CAV).” Belgium · not specified · pilot or niche | weak (company, news, market research, other) eimeriaprevention.com |
| The switch to vaccination in Belgium was driven by political expectations concerning antimicrobial resistance and the need for sustainable policies. “All these data show that the implementation of a coccidiosis vaccination in a rotation programme for coccidiosis control could be one of the solutions to respond to the political expectations concerning antimicrobial resistance.” Belgium · not specified · not applicable | weak (company, news, market research, other) eimeriaprevention.com |
| Norway discontinued the prophylactic use of coccidiostats in broiler production in 2016, and all broiler flocks are now routinely vaccinated at hatch. “Norway discontinued the prophylactic use of coccidiostats in broiler production in 2016, and all broilers are now raised without the routine use of coccidiostats. As an alternative strategy to control coccidiosis, all broiler flocks in Norway are now routinely vaccinated at hatch with vaccines based on live attenuated …” Norway · 2016-present · majority share of a major market | weak (company, news, market research, other) nva.sikt.no |
| In Canada, coccidiosis vaccines were administered in 13% of broiler chicken flocks, 16% of turkey flocks, and 29% of layer flocks in the 2018-2023 period. “coccidiosis vaccines were administered in 13% of broiler chicken flocks, 16% of turkey flocks, and 29% of layer flocks.” Canada · 2018-2023 · minority but measured share or volume | peer-reviewed ✓ exa.ai |
| Raised Without Antibiotic programs, which include removing ionophores from diets, represent approximately 50% of USA poultry production. “‘Raised Without Antibiotic’ programmes (includes removing ionophores from diets) now represent approximately 50% of USA poultry production, has resulted in compromised production results as illustrated in Table 1.” USA · 2021 · majority share of a major market | peer-reviewed ✓ exa.ai |
References 4
- Chapman HD, Cherry TE, Danforth HD, et al. (2002). Sustainable coccidiosis control in poultry production: the role of live vaccines. *International Journal for VERIFIED DOI · cited by 209
- Chapman HD, Jeffers TK (2014). Vaccination of chickens against coccidiosis ameliorates drug resistance in commercial poultry production. *International Journal VERIFIED DOI · cited by 122
- Blake DP, Tomley FM (2014). Securing poultry production from the ever-present *Eimeria* challenge. *Trends in Parasitology* 30: 12–19. VERIFIED DOI · cited by 394
- Dorne JL, Fernández-Cruz ML, Bertelsen U, et al. (2013). Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects. *To VERIFIED DOI · cited by 123
Details
Replaces: continuous in-feed ionophores and chemical anticoccidials · Species: poultry · Evidence: high
The chemical problem#
Almost all conventional broilers receive anticoccidials in feed for their whole life. Ionophores are extremely toxic to horses (monensin LD₅₀ in horses about 2–3 mg/kg bw), and accidental feed contamination has killed many horses, cattle and dogs worldwide. Eimeria parasites have developed resistance to all anticoccidial drugs used for long periods. Ionophores are antibacterial, and in Scandinavia and the EU, narasin-resistance genes (narAB) in Enterococcus have been linked to ionophore use. Residues in eggs from cross-contamination of layer feed are a recurring food-safety finding.
Product overview#
Live coccidiosis vaccines contain live oocysts of the relevant Eimeria species, either attenuated (precocious lines) or wild-type sensitive strains. Chicks receive them at the hatchery (spray, gel drops) or in the first water. The vaccinated birds develop protective immunity through controlled low-level infection and cycling in the litter.
- Attenuated vaccines: Paracox-5/8, Livacox, Hipracox, Evant, Eimeriavax.
- Non-attenuated: Coccivac, Immucox, Advent (wild, drug-sensitive strains). Vaccines are standard in breeders and layers (nearly 100 %) and increasingly used in broilers (antibiotic-free programs in the USA and EU). A useful side effect: vaccinating for several cycles restores drug sensitivity in farm Eimeria populations, because vaccine strains are drug-sensitive.
Support: phytogenic feed additives (oregano essential oil/carvacrol, saponins from Yucca/Quillaja, Artemisia annua), Bacillus probiotics (V01), betaine, and litter management.
Active ingredient / Composition#
Live sporulated oocysts of E. acervulina, E. maxima, E. tenella, E. necatrix, E. brunetti, E. mitis, E. praecox (the composition depends on the product and the bird type).
Key facts#
| Parameter | Value |
|---|---|
| Class | Live parasite vaccine (immunization) |
| Administration | Day 0–3: hatchery spray/gel or drinking water (per SmPC) |
| Immunity | Develops after 2–3 oocyst cycles (about 3 weeks) |
| Withdrawal | Zero days |
| Horse/other species toxicity | None |
Advantages#
- Eliminates ionophore toxicity risk and residues.
- Restores drug sensitivity of farm Eimeria populations (“rotation” of vaccine with drugs).
- Suits antibiotic-free/“no ionophore” production (the US NAE programs).
- Long-lasting immunity for breeders and layers.
Mode of action#
Controlled infection with low doses (attenuated or drug-sensitive) triggers cell-mediated immunity (T cells, IFN-γ) in the gut. Reinfection by field strains is blocked. Attenuated precocious lines have a shorter life cycle and lower oocyst output, so less pathology.
Application#
| Bird type | Program | Specifics |
|---|---|---|
| Broiler breeders, layers | Live vaccine at day 0–3 | Do not use anticoccidials in feed after vaccination (they block immunity) |
| Broilers (whole cycle) | Vaccine at the hatchery + phytogenic/probiotic support | Uniform application, correct litter moisture (oocyst cycling needs moisture of about 25–30 %) |
| Broilers (rotation) | 2–4 vaccine cycles → then drug cycles → back to vaccine | “Bio-shuttle”: restores drug sensitivity |
| All | Litter and ventilation | Too-wet litter → coccidiosis and necrotic enteritis |
Limitations#
- A short performance dip at 3–4 weeks (the immunity-building phase) in broilers; offset by good management.
- Coccidiosis vaccines cost more per bird than ionophores (partly offset by health and resistance benefits).
- Vaccine coverage must be uniform (spray cabinet quality control).
Evidence of displacement — D2: measurable displacement (minority share)#
Assessment (hand-reviewed): One national survey: live coccidiosis vaccines used in 13% of broiler, 16% of turkey and 29% of layer flocks (peer-reviewed).
Verified figures (the number is in the quoted sentence and the sentence is on the source page):
- driver — In Canada, coccidiosis vaccines were administered in 13% of broiler chicken flocks, 16% of turkey flocks, and 29% of layer flocks in the 2018-2023 period. (Canada, 2018-2023; peer-reviewed: exa.ai)
- driver — Raised Without Antibiotic programs, which include removing ionophores from diets, represent approximately 50% of USA poultry production. (USA, 2021; peer-reviewed: exa.ai)
Suppliers — real products and services (from the vendor index)#
Honest finding: the vendor index has no card that names a live coccidiosis vaccine; entries are poultry-vaccine makers (closest capability). This is recorded as a supplier gap — the companies below are the closest capabilities.
Companies below are active vendors in the vendor index whose own card (profile / official website) shows this product or service — matched 2026-09-28 by keyword and checked by hand against the card text. Being listed is not an endorsement; open each card for evidence, contacts and status.
| Company | Region · Country | What the index shows | Card |
|---|---|---|---|
| Vaksindo Animal Health | Asia · Indonesia | poultry vaccines (Indonesia’s first animal-vaccine maker) | card |
| Biocamp Laboratórios Ltda | LatAm · Brazil | poultry vaccines (CampVac line) | card |
| Liselo Labs | Africa/ME · South Africa | E. coli vaccine for poultry; antibiotic alternatives | card |
| MSD Animal Health Poultry and Swine Sub Sahara Africa | Africa/ME · South Africa | poultry vaccine range incl. intestinal diseases (Merck subsidiary) | card |
| International Free Trade Corporation - IFT | Africa/ME · Egypt | vaccines and biologicals for production animals | card |
Government funding signals#
Public grants for a specific technology are a leading indicator: governments fund what regulators want to replace and what is close to practical adoption. Searched on 2026-09-27 in: EU CORDIS (FP7, Horizon 2020, Horizon Europe), US federal awards (USAspending: USDA NIFA/ARS/APHIS/Forest Service, EPA, DOE, NOAA, USAID; plus NSF and NIH), UK UKRI Gateway to Research, Australian Research Council. Each grant below was reviewed by hand for relevance. China, Brazil and India are covered in the subsection below (publication-acknowledged grants). Not covered: Russia (RSF, FASIE — not reachable from the research environment) and national agencies outside these databases. Amounts are the funder’s contribution as recorded (US NIH/UKRI: per award or fiscal year).
Signal: Moderate. 3 relevant grant(s) · about €2.3M in total · jurisdictions: UK.
| Funder / programme | Project | Lead organisation | Start | Amount | Link |
|---|---|---|---|---|---|
| UKRI — BBSRC | Anticoccidial vaccine development: the importance of genetic diversity and delivery strategy | (UK) | 2010 | 867,141 GBP | link |
| UKRI — ISPF | Reducing reliance on ionophores: Eimeria population biology and impact on selection for antimicrobial resistance | Pathobiology And Population Sciences (UK) | 2024 | 703,374 GBP | link |
| UKRI — BBSRC | VACCINE. Development of a novel yeast-based oral subunit vaccine against Eimeria spp. in chickens | Pathology And Pathogen Biology (UK) | 2016 | 400,104 GBP | link |
China, Brazil, India — national research grants acknowledged in publications#
Chinese, Brazilian and Indian funders have no open grant databases reachable here, so this measures scientific papers published since 2015 that acknowledge national government grants, taken from the grant numbers publishers deposit with Crossref. Only papers whose title contains this article’s key terms are counted (a conservative lower bound; “100+” = search window full). It shows research-funding intensity, not budgets. Funders: China — NSFC, National Key R&D Program, China Agriculture Research System; Brazil — CNPq, CAPES, FAPESP, Embrapa, FAPEMIG; India — DBT, DST, ICAR, SERB, CSIR, BIRAC. Rating per country: Strong ≥50 papers · Moderate 10–49 · Weak 1–9.
| Country | Papers funded (2015–2026) | Signal | Main funders (grant acknowledgements) | Example grant → funded paper |
|---|---|---|---|---|
| China | 24 | Moderate | NSFC (33), National Key R&D Program (11), China Agriculture Research System (1) | National Key R&D Program 2023YFD1801200 → Conserved proteins of Eimeria and their applications to develop universal subunit vaccine against chicken… (2024) doi |
| Brazil | 2 | Weak | CAPES (2), CNPq (1) | – |
| India | 0 | None | – | – |
Scientific evidence#
- Chapman HD, Cherry TE, Danforth HD, et al. (2002). Sustainable coccidiosis control in poultry production: the role of live vaccines. International Journal for Parasitology 32: 617–629.
- Chapman HD, Jeffers TK (2014). Vaccination of chickens against coccidiosis ameliorates drug resistance in commercial poultry production. International Journal for Parasitology: Drugs and Drug Resistance 4: 214–217.
- Blake DP, Tomley FM (2014). Securing poultry production from the ever-present Eimeria challenge. Trends in Parasitology 30: 12–19.
- Dorne JL, Fernández-Cruz ML, Bertelsen U, et al. (2013). Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects. Toxicology and Applied Pharmacology 270: 196–208.
Bioeconomy value#
A biological (live-organism) vaccine produced in bioprocess facilities replaces continuous medicated feed. It also improves safety for other livestock and companion animals.